BioSpace News Archive

Dexcom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring systems.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today results for the first time from the Phase 2 CARTITUDE-2 Cohort D study in multiple myeloma patients.

Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences.

Electromed, Inc., a leader in innovative airway clearance technologies, announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti June Small-Cap Virtual Conference on June 12-13, 2024.

Structure Therapeutics Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed underwritten public offering of 8,000,000 American depositary shares, each representing three ordinary shares.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease.

Tectonic Therapeutic, Inc. today announced the appointment of Daniel Lochner as Chief Financial Officer of Tectonic.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company granted an aggregate of 9,500 restricted stock units to three newly-hired employees.

Poseida Therapeutics, Inc. announced that its virtual Annual Meeting of Stockholders will be held on Monday, June 17, 2024 at 1:00 p.m. PT.

Amgen will present at Jefferies Global Healthcare Conference at 9:00 a.m. ET on Thursday, June 6, 2024.